Implantable cardioverter defibrillators vs beta‐blocker
All‐cause mortality · people with cardiac channelopathies
Implantable cardioverter defibrillators may leads to lower all‐cause mortality compared with β‐blocker therapy (low certainty).
1 finding from 1 review
- Implantable defibrillators versus medical therapy for cardiac channelopathies 2015 · Cochrane Headline outcomes onlyRR 0.11 [0.01, 0.83]2 studies · 86 participantsLow